The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors
- UMASS, MED
- Research Organization:
- Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- National Institutes of Health (NIH)
- OSTI ID:
- 1094849
- Journal Information:
- PLoS Patho., Vol. 8, Issue (7) ; 07, 2012
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Evaluating the Role of Macrocycles in the Susceptibility of Hepatitis C Virus NS3/4A Protease Inhibitors to Drug Resistance
Hepatitis C virus NS3/4A inhibitors and other drug-like compounds as covalent binders of SARS-CoV-2 main protease
The prevalence of the pre-existing hepatitis C viral variants and the evolution of drug resistance in patients treated with the NS3-4a serine protease inhibitor telaprevir
Journal Article
·
Tue Sep 01 00:00:00 EDT 2020
· ACS Chem. Biol.
·
OSTI ID:1094849
+9 more
Hepatitis C virus NS3/4A inhibitors and other drug-like compounds as covalent binders of SARS-CoV-2 main protease
Journal Article
·
Sat Jul 16 00:00:00 EDT 2022
· Scientific Reports
·
OSTI ID:1094849
+12 more
The prevalence of the pre-existing hepatitis C viral variants and the evolution of drug resistance in patients treated with the NS3-4a serine protease inhibitor telaprevir
Journal Article
·
Tue Jan 01 00:00:00 EST 2008
· PLoS computational biology
·
OSTI ID:1094849